Tom Harkin actually said...

When you consider how much funding was needed to keep up with inflation, the cut was more like $1.3 billion.

Fortunately, the Senate rejected that plan.

It seems to me this is about as important as Gleevec. I mean, this attacks metastatic melanoma in later stages.

And this has always been a death sentence before.